Backgroundβ-Alanine (βA) has been shown to improve performance during cycling. This study was the first to examine the effects of βA supplementation on the onset of blood lactate accumulation (OBLA) during incremental treadmill running.MethodsSeventeen recreationally-active men (mean ± SE 24.9 ± 4.7 yrs, 180.6 ± 8.9 cm, 79.25 ± 9.0 kg) participated in this randomized, double-blind, placebo-controlled pre/post test 2-treatment experimental design. Subjects participated in two incremental treadmill tests before and after 28 days of supplementation with either βA (6.0 g·d-1)(βA, n = 8) or an equivalent dose of Maltodextrin as the Placebo (PL, n = 9). Heart rate, percent heart rate maximum (%HRmax), %VO2max@OBLA (4.0 mmol.L-1 blood lactate concentration) and VO2max (L.min-1) were determined for each treadmill test. Friedman test was used to determine within group differences; and Mann-Whitney was used to determine between group differences for pre and post values (p < 0.05).ResultsThe βA group experienced a significant rightward shift in HR@OBLA beats.min-1 (p < 0.01) pre/post (161.6 ± 19.2 to 173.6 ± 9.9) but remained unchanged in the PL group (166.8 ± 15.8 to 169.6 ± 16.1). The %HRmax@OBLA increased (p < 0.05) pre/post in the βA group (83.0% ± 9.7 to 88.6% ± 3.7) versus no change in the PL group (86.3 ± % 4.8 to 87.9% ± 7.2). The %VO2max@OBLA increased (p < 0.05) in the βA group pre/post (69.1 ± 11.0 to 75.6 ± 10.7) but remained unchanged in the PL group (73.3 ± 7.3 to 74.3 ± 7.3). VO2max (L.min-1) decreased (p < 0.01) in the βA group pre/post (4.57 ± 0.8 to 4.31 ± 0.8) versus no change in the PL group (4.04 ± 0.7 to 4.18 ± 0.8). Body mass kg increased (p < 0.05) in the βA group pre/post (77.9 ± 9.0 to 78.3 ± 9.3) while the PL group was unchanged (80.6 ± 9.1 to 80.4 ± 9.0).ConclusionsβA supplementation for 28 days enhanced sub-maximal endurance performance by delaying OBLA. However, βA supplemented individuals had a reduced aerobic capacity as evidenced by the decrease in VO2max values post supplementation.
The new 7SKF equation improved on SKF equations developed using densitometry. The final equation based on the whole sample was %BF' = 10.566 + 0.12077*(7SKF) - 8.057*(gender) - 2.545*(race). Moreover, a 3SKF equation was comparable in accuracy to the 7SKF equation: BF' = 8.997 + 0.24658*(3SKF) - 6.343*(gender) - 1.998*(race).
Background: Muscle mass, strength and fitness play a role in lower-extremity physical function (LEPF) in older adults; however, the relationships remain inadequately characterized. Objective: This study aimed to examine the relationships between leg mineral free lean mass (MFLMLEG), leg muscle quality (leg strength normalized for MFLMLEG), adiposity, aerobic fitness and LEPF in community-dwelling healthy elderly subjects. Methods: Fifty-five older adults (69.3 ± 5.5 years, 36 females, 19 males) were assessed for leg strength using an isokinetic dynamometer, body composition by dual energy X-ray absorptiometry and aerobic fitness via a treadmill maximal oxygen consumption test. LEPF was assessed using computerized dynamic posturography and stair ascent/descent, a timed up-and-go task and a 7-meter walk with and without an obstacle. Results: Muscle strength, muscle quality and aerobic fitness were similarly correlated with static LEPF tests (r range 0.27–0.40, p < 0.05); however, the strength of the independent predictors was not robust with explained variance ranging from 9 to 16%. Muscle quality was the strongest correlate of all dynamic LEPF tests (r range 0.54–0.65, p < 0.001). Using stepwise linear regression analysis, muscle quality was the strongest independent predictor of dynamic physical function explaining 29–42% of the variance (p < 0.001), whereas aerobic fitness or body fat mass explained 5–6% of the variance (p < 0.05) depending on performance measure. Conclusions: Muscle quality is the most important predictor, and aerobic fitness and fat mass are secondary predictors of LEPF in community-dwelling older adults. These findings support the importance of exercise, especially strength training, for optimal body composition, and maintenance of strength and physical function in older adults.
Objective-To determine the sex-specific relationships between physical activity, aerobic fitness, adiposity (%Fat), mineral-free lean mass (MFLM) and balance and gait performance in older adults.Design-Eighty-five female and 49 male sedentary, healthy, community-dwelling older adults (M ±SD; 69.6±5.4 and 70.3±4.7 years, respectively) were evaluated on habitual physical activity via questionnaire, aerobic fitness by a maximal oxygen consumption treadmill test, whole and regional body composition by DXA, and lower-extremity physical function (LEPF) using gait tasks and computerized dynamic posturography.Results-As expected, males had less body fat, more lean mass and higher aerobic fitness than females, and tended to perform better on all LEPF tasks (all p≤0.1). Physical activity was not related to gait; however, fitness was related to gait in both sexes (r>0.50, all p<0.05). Body fat was related to gait in women (r=−0.38, p<0.05) but not men. Neither fitness nor body composition was related to balance in men, whereas in women leg MFLM was positively associated (r=0.27, p<0.05). Women, but not men, with a greater body weight to leg MFLM ratio performed worse on gait tasks (p<0.001).There was an interaction with sex for %Fat on gait (p=0.05), and for MFLM LEG on balance (p<0.05).Conclusions-In sedentary healthy older adults the relation between body composition, aerobic fitness and balance and gait differs between sexes such that women are more strongly impacted by alterations in body composition. Lower %Fat and preservation of lower body lean mass have important implications for reducing the risk of physical disability, especially in older women.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.